HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 547/3/941    most recent 2002.033183v1 Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ivanov, A. I. Articles by Romanovsky, A. A. Search for Related Content PubMed PubMed Citation Articles by Ivanov, A. I. Articles by Romanovsky, A. A.

Role for the cholecystokinin-A receptor in fever: a study of a mutant rat strain and a pharmacological analysis

Andrei I. Ivanov*, Vladimir A. Kulchitsky* and Andrej A. Romanovsky*†

The involvement of the cholecystokinin (CCK)-A receptor in fever was studied. The polyphasic febrile responses to lipopolysaccharide (LPS; 10 µg kg^-1, I.V.) were compared between wild-type Long-Evans (LE) rats and the CCK-A-receptor-deficient Otsuka LE Tokushima Fatty (OLETF) rats. The response of the wild-type rats was biphasic, which is typical for LE rats. Phases 1 and 2 of the response of the OLETF rats were similar to those of the LE rats, but the OLETF rats also developed a robust phase 3. This late enhancement of the febrile response could reflect either the absence of the A receptor per se or a secondary trait of the mutant strain. To distinguish between these possibilities, we conducted a pharmacological analysis. We studied whether the normally low phase 3 of LE rats can be enhanced by a CCK-A-receptor antagonist, sodium lorglumide (4.3 µg kg^-1 min^-1, 120 min, I.V.), and whether the normally high phase 3 of Wistar rats can be attenuated by a CCK-A receptor agonist, sulphated CCK-8 (up to 0.17 µg kg^-1 min^-1, 120 min, I.V.). The dose of sodium lorglumide used was sufficient to increase food intake (to block satiety), but it did not affect the fever response. In both febrile and afebrile rats, CCK-8 induced dose-dependent skin vasodilatation and decreased body temperature, but it failed to produce any effects specific for phase 3. We conclude that the exaggeration of phase 3 in OLETF rats reflects a secondary trait of this strain and not the lack of the CCK-A receptor per se. None of the three known phases of the febrile response of rats to LPS requires the CCK-A receptor.

This article has been cited by other articles:

				T. J. Weiland, N. J. Voudouris, and S. Kent CCK2 receptor nullification attenuates lipopolysaccharide-induced sickness behavior Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R112 - R123. [Abstract] [Full Text] [PDF]

				Z. Szelenyi Neuronal CCK and thermoregulation: two receptors with different functions Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R109 - R111. [Full Text] [PDF]

				A. A. Steiner, A. Y. Rudaya, J. R. Robbins, A. S. Dragic, R. Langenbach, and A. A. Romanovsky Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1253 - R1257. [Abstract] [Full Text] [PDF]

				A. A. Romanovsky, N. Sugimoto, C. T. Simons, and W. S. Hunter The organum vasculosum laminae terminalis in immune-to-brain febrigenic signaling: a reappraisal of lesion experiments Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R420 - R428. [Abstract] [Full Text] [PDF]